+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls



Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls



British Journal of Psychiatry 147: 276-282



Compared to healthy controls, unmedicated schizophrenic patients had significantly higher plasma concentrations of taurine, methionine, valine, isoleucine, leucine, phenylalanine, and lysine. Except for taurine, these amino acids share the L-transport system for neutral amino acids. In the patients, homovanillic (HVA) acid levels in CSF were decreased and the plasma levels of the amino acids competing with tyrosine and tryptophan for transport into the brain, were all negatively correlated to the CSF concentrations of HVA and 5-HIAA. These findings could be explained by a change in the affinity of the L-system or by a decrease in its overall capacity in schizophrenia. Raised plasma levels of the competing amino acids may limit the brain uptake of tyrosine, leading to a diminished dopamine turnover, and resulting in a compensatory development of supersensitive dopamine receptors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 006127553

Download citation: RISBibTeXText

PMID: 2415198

DOI: 10.1192/bjp.147.3.276


Related references

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research 9(4): 301-308, 1983

Plasma amino acids and cerebrospinal fluid monoamine metabolites in obesity. International Journal of Obesity 18(Suppl. 2): 118, 1994

Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls. Psychiatry Research 6(1): 77-83, 1982

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Research 4(1): 21-29, 1981

Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls. British Journal of Industrial Medicine 47(4): 277-280, 1990

Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid. European Journal Of Pharmacology. 230(3): 321-326, 1993

Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry Research 11(2): 107-110, 1984

Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biological Psychiatry 14(3): 509-523, 1979

Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology 99(3): 322-327, 1989

Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. Journal of Neurochemistry 42(3): 833-837, 1984

Cerebrospinal fluid amino acids in pathological gamblers and healthy controls. Neuropsychobiology 56(2-3): 152-158, 2007

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Archives of General Psychiatry 47(7): 641-648, 1990

Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients. Psychopharmacology 101(3): 324-331, 1990

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biological Psychiatry. 33(8-9): 636-641, 1993

Corticotropin releasing factor like immunoreactivity in cerebrospinal fluid in normal controls and major depression relationship to cerebrospinal fluid monoamine metabolites dexamethasone suppression test and trh stimulation test results. Society for Neuroscience Abstracts 10(2): 1093, 1984